A Study of Golimumab (CNTO 148) Administered in Combination With Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis.
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2013
At a glance
- Drugs Golimumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms GO-FORTH
- 26 Jun 2012 Actual patient number changed from 276 to 269 to as reported by ClinicalTrials.gov.
- 09 Jun 2012 Results presented at the 13th Annual Congress of the European League Against Rheumatism.
- 20 Mar 2012 Actual patient number changed from 269 to 276 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History